JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB216842

Anti-HIF-1 alpha antibody

Be the first to review this product! Submit a review

|

(52 Publications)

Rabbit Polyclonal HIF-1 alpha antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Human samples. Cited in 52 publications. Immunogen corresponding to Synthetic Peptide within Human HIF1A aa 350-400 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

BHLHE78, MOP1, PASD8, HIF1A, Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, Class E basic helix-loop-helix protein 78, Member of PAS protein 1, PAS domain-containing protein 8, bHLHe78

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody (AB216842)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody (AB216842)

Hela cell; 4% Paraformaldehyde-fixed; Triton X-100 at room temperature for 20 min; Blocking buffer (normal goat serum) at 37°C for 20 min; Antibody incubation with HIF-1 Alpha polyclonal Antibody (1/100, ab216842), 90 minutes at 37°C; followed by a conjugated Goat Anti-Rabbit IgG antibody at 37°C for 90 minutes, DAPI (blue) was used to stain the cell nuclei.

Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody (AB216842)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-HIF-1 alpha antibody (AB216842)

Mouse spleen cells were fixed with 4% PFA for 10min at room temperature, permeabilized with 90% ice-cold methanol for 20 min at -20℃, and incubated in 5% BSA blocking buffer for 30 min at room temperature. Cells were then stained with HIF-1 Alpha Antibody (ab216842) at 1 : 50 dilution in blocking buffer and incubated for 30 min at room temperature, washed twice with 2%BSA in PBS, followed by secondary antibody incubation for 40 min at room temperature. Acquisitions of 20,000 events were performed. Cells stained with primary antibody (green), and isotype control (orange).

Western blot - Anti-HIF-1 alpha antibody (AB216842)
  • WB

Supplier Data

Western blot - Anti-HIF-1 alpha antibody (AB216842)

Cell lysate was first probed with primary antibody (ab216842) at 4°C overnight then incubated with conjugated secondary antibody for 60 min at 37˚C.

All lanes:

Western blot - Anti-HIF-1 alpha antibody (ab216842) at 1/1000 dilution

All lanes:

U-87MG cell lysate

Secondary

All lanes:

Conjugated secondary antibody at 1/20000 dilution

Predicted band size: 92 kDa

false

Western blot - Anti-HIF-1 alpha antibody (AB216842)
  • WB

Supplier Data

Western blot - Anti-HIF-1 alpha antibody (AB216842)

Cell lysate was first probed with primary antibody (ab216842) at 4°C overnight then incubated with conjugated secondary antibody for 90 min at 37˚C.

All lanes:

Western blot - Anti-HIF-1 alpha antibody (ab216842) at 1/300 dilution

All lanes:

HL60 cell lysate

Secondary

All lanes:

Goat Anti-Rabbit IgG Antibody (H+L), HRP at 1/5000 dilution

Predicted band size: 92 kDa

false

Western blot - Anti-HIF-1 alpha antibody (AB216842)
  • WB

Supplier Data

Western blot - Anti-HIF-1 alpha antibody (AB216842)

Cell lysates were first probed with primary antibody (ab216842) at 4°C overnight then incubated with conjugated secondary antibody for 60 min at 37˚C.

All lanes:

Western blot - Anti-HIF-1 alpha antibody (ab216842) at 1/1000 dilution

Lane 1:

Hela cell lysate

Lane 2:

A431 cell lysate

Lane 3:

U251 cell lysate

Lane 4:

HepG2 cell lysate

Secondary

All lanes:

Conjugated secondary antibody at 1/20000 dilution

Predicted band size: 92 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

WB, Flow Cyt (Intra), ICC/IF

applications

Immunogen

Synthetic Peptide within Human HIF1A aa 350-400 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

Q16665

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/300 - 1/1000", "WB-species-notes": "<p>Ensure cell lysis occurs quickly if removed from hypoxia. Ultrasonic lysis is recommended to enrich more nuclear lysate.</p><p>Positive Control: Hypoxic samples such as HeLa-DFO treated whole cell lysate <a href='/en-us/products/unavailable/hela-dfo-treated-05mm-24h-whole-cell-lysate-ab116322'>ab116322</a>. For a stronger signal, HeLa-DFO treated nuclear extracts are recommended <a href='/en-us/products/tissue-lysates/hela-dfo-treated-05mm-24h-nuclear-lysate-ab180880'>ab180880</a>. The cell fractionation kit can also be purchased separately <a href='/en-us/products/sample-preparation-kits/cell-fractionation-kit-standard-ab109719'>ab109719</a>. Negative Control: Most normal tissues or cells, other than kidney or heart.</p><p>The observed band size of HIF-1 alpha is not exactly as predicted due to the different forms of HIF-1 alpha below:<br>40-80 kDa - degraded; 10-130 kDa - post translationally modified; ~200 kDa - heterodimer with HIF-1 beta</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/200", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/300 - 1/1000", "WB-species-notes": "<p>Ensure cell lysis occurs quickly if removed from hypoxia. Ultrasonic lysis is recommended to enrich more nuclear lysate.</p><p>Positive Control: Hypoxic samples such as HeLa-DFO treated whole cell lysate <a href='/en-us/products/unavailable/hela-dfo-treated-05mm-24h-whole-cell-lysate-ab116322'>ab116322</a>. For a stronger signal, HeLa-DFO treated nuclear extracts are recommended <a href='/en-us/products/tissue-lysates/hela-dfo-treated-05mm-24h-nuclear-lysate-ab180880'>ab180880</a>. The cell fractionation kit can also be purchased separately <a href='/en-us/products/sample-preparation-kits/cell-fractionation-kit-standard-ab109719'>ab109719</a>. Negative Control: Most normal tissues or cells, other than kidney or heart.</p><p>The observed band size of HIF-1 alpha is not exactly as predicted due to the different forms of HIF-1 alpha below:<br>40-80 kDa - degraded; 10-130 kDa - post translationally modified; ~200 kDa - heterodimer with HIF-1 beta</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/200", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/20 - 1/100", "FlowCytIntra-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Proclin 300 Constituents: 50% Glycerol (glycerin, glycerine), 48.98% TBS, 1X, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HIF-1 alpha also known as hypoxia-inducible factor 1-alpha is a transcription factor critical in cellular response to low oxygen levels. Its molecular weight usually ranges from 93 to 120 kDa. You can find HIF-1 alpha expressed in tissues throughout the body but its expression significantly increases under hypoxic conditions. Researchers often use the HIF-1a ELISA to measure its expression levels. HIF-1 alpha forms a complex with other proteins to perform its functions effectively.
Biological function summary

HIF-1 alpha regulates gene expression in response to hypoxic conditions in cells. It forms a complex with HIF-1 beta to activate transcription of various genes involved in energy metabolism angiogenesis and erythropoiesis. HIF-1 alpha enables cells to adapt to reduced oxygen availability allowing for cellular survival and function under stress. It plays an important role in promoting the expression of genes like VEGF and EPO which are important for vascular and red blood cell development respectively.

Pathways

HIF-1 alpha plays an integral role in the hypoxia signaling pathway and the glycolytic pathway. In the hypoxia signaling pathway HIF-1 alpha partners with VHL (Von Hippel-Lindau) protein that regulates its degradation under normal oxygen conditions. When oxygen levels drop HIF-1 alpha avoids degradation stabilizes and translocates into the nucleus to initiate transcription of hypoxia-responsive genes. The glycolytic pathway involvement highlights its function in adapting energy production under hypoxic conditions through collaboration with enzymes and transporters associated with glycolysis.

HIF-1 alpha has been implicated in cancer and ischemic diseases. Its role in promoting angiogenesis and metabolic adaptation makes it a contributor to tumor growth and survival collaborating with oncogenes such as c-Myc. In ischemic diseases like stroke or myocardial infarction HIF-1 alpha's ability to induce protective responses can mitigate tissue damage through regulation of survival pathways. Understanding these interactions helps in the development of therapeutic strategies targeting HIF-1 alpha in disease contexts.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The protein expressed by the gene HIF1A functions as a master transcriptional regulator of the adaptive response to hypoxia, activating the transcription of over 40 genes under hypoxic conditions, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and others. These genes' protein products enhance oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF1A is crucial for embryonic vascularization, tumor angiogenesis, and ischemic disease pathophysiology. Its activation requires transcriptional coactivators like CREBBP and EP300, with activity enhanced by interactions with NCOA1 and/or NCOA2. Interaction with redox regulatory protein APEX1 activates CTAD and enhances activation by NCOA1 and CREBBP. Additionally, HIF1A is involved in axonal distribution and mitochondrial transport in neurons during hypoxia. In the context of microbial infection, specifically human coronavirus SARS-CoV-2, HIF1A is necessary for glycolysis induction in monocytes, leading to a proinflammatory state, inducing expression of ACE2, cytokines, and promoting virus replication and monocyte inflammatory response. This supplementary information is collated from multiple sources and compiled automatically.
See full target information HIF1A

Publications (52)

Recent publications for all applications. Explore the full list and refine your search

Stem cells translational medicine 14: PubMed40213860

2025

Reprogramming of skin fibroblasts by 3D spheroid culture promotes peripheral nerve regeneration via the ID3/semaphorin7a pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xu Tan,Zhou Zhang,Xiaohui Cao,Langfan Qu,Yinchun Xiong,Huijuan Li,Yu Wang,Zelin Chen,Chunmeng Shi

JCI insight 9: PubMed38271096

2024

Purine nucleoside phosphorylase inhibition is an effective approach for the treatment of chemical hemorrhagic cystitis.

Applications

Unspecified application

Species

Unspecified reactive species

Amanda Wolf-Johnston,Youko Ikeda,Irina Zabbarova,Anthony J Kanai,Sheldon Bastacky,Robert Moldwin,Joel Nh Stern,Edwin K Jackson,Lori A Birder

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2306143 PubMed38083984

2023

A Novel Cargo Delivery System-AnCar-Exo Ameliorates Arthritis via Specifically Targeting Pro-Inflammatory Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Song Li,Ya-Ran Wu,Xiu-Qin Peng,Han-Gang Chen,Tong-Yi Zhang,Hua Chen,Jing Yang,Yang-Li Xie,Hua-Bing Qi,Wei Xiang,Bo Huang,Si-Ru Zhou,Yan Hu,Qiao-Yan Tan,Xiao-Lan Du,Jun-Lan Huang,Ruo-Bin Zhang,Xiao-Hong Li,Feng-Tao Luo,Min Jin,Nan Su,Xiao-Qing Luo,Shuo Huang,Peng Yang,Xiao-Jing Yan,Ji-Qin Lian,Ying Zhu,Yan Xiong,Gong-Yi Xiao,Ying-Ying Liu,Chen Shen,Liang Kuang,Zhen-Hong Ni,Lin Chen

Immunity, inflammation and disease 11:e835 PubMed37647427

2023

TFRC in cardiomyocytes promotes macrophage infiltration and activation during the process of heart failure through regulating Ccl2 expression mediated by hypoxia inducible factor-1α.

Applications

Unspecified application

Species

Unspecified reactive species

Yanyun Pan,Jinxiu Yang,Jin Dai,Xiaoming Xu,Xinbin Zhou,Wei Mao

Journal of tissue engineering and regenerative medicine 2023:8818561 PubMed40226419

2023

The Effect of Distraction Osteogenesis on Peripheral Nerve Regeneration in Rats: A Preliminary Study .

Applications

Unspecified application

Species

Unspecified reactive species

Kai Liu,Yuanxin Chen,Feiyu Cai,Xin Wang,Chenchen Fan,Peng Ren,Aihemaitijiang Yusufu,Yanshi Liu

Open medicine (Warsaw, Poland) 18:20230700 PubMed37215053

2023

NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yicheng Tian,Longjiang Shao,Qi Wang,Gan Ru,Chuntao Zhai,Lihui Zhou

Journal of advanced research 56:31-41 PubMed36933884

2023

Polystyrenenanoplastics lead to ferroptosis in the lungs.

Applications

Unspecified application

Species

Unspecified reactive species

Yuhao Wu,Junke Wang,Tianxin Zhao,Mang Sun,Maozhu Xu,Siyi Che,Zhengxia Pan,Chun Wu,Lianju Shen

Journal of orthopaedic surgery and research 18:169 PubMed36872328

2023

Diabetes mellitus impairs bone regeneration and biomechanics.

Applications

Unspecified application

Species

Unspecified reactive species

Feiyu Cai,Yanshi Liu,Kai Liu,Ruomei Zhao,Wenjiao Chen,Aihemaitijiang Yusufu,Yi Liu

Frontiers in immunology 13:946794 PubMed36003373

2022

Substratum interactions determine immune response to allogeneic transplants of endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Elise C Wilcox,Elazer R Edelman

Investigative ophthalmology & visual science 63:25 PubMed35895036

2022

LGALS3BP in Microglia Promotes Retinal Angiogenesis Through PI3K/AKT Pathway During Hypoxia.

Applications

Unspecified application

Species

Unspecified reactive species

Chenyang Zhao,Yusen Liu,Jiayu Meng,Xiaotang Wang,Xianyang Liu,Wanqian Li,Qian Zhou,Junjie Xiang,Na Li,Shengping Hou
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com